HBK Investments’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

HBK Investments’s Portfolio GWPH Stock Details GWPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-1,348,216	Closed	-$292M	–	1109
2021 Q1	$292M	Buy	+1,348,216	New	+$253M	1.32%	12
2016 Q2	–	Sell	-19,232	Closed	-$1.39M	–	1136
2016 Q1	$1.39M	Sell	19,232 -18,592	-49%	-$1.02M	0.01%	517
2015 Q4	$2.63M	Buy	37,824 +25,277	+201%	+$2.06M	0.02%	350
2015 Q3	$1.15M	Buy	+12,547	New	+$1.4M	0.01%	556

Other funds holding GWPH

HDIM

Hanson & Doremus Investment Management Burlington, Vermont $983M AUM 34.23% 1-Year Est. Return

HBK Investments's GWPH Position: Q2 2021 in Review

HBK Investments sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q2 2021, closing a stake of 1,348,216 shares — an estimated $292M sold.

HBK Investments first reported a position in GWPH in Q3 2015 and held it in 4 quarters. The position peaked at $292M in Q1 2021. 1 fund tracked by Wall St. Rank holds GWPH as of Q2 2021.

HBK Investments reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q2 2021 after selling out during the quarter.
HBK Investments sold 1,348,216 GW Pharmaceuticals Plc American Depositary Shares shares in Q2 2021, an estimated $292M.
HBK Investments first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q3 2015 and held it in 4 quarters.
HBK Investments's GW Pharmaceuticals Plc American Depositary Shares position peaked at $292M in Q1 2021.
1 fund tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q2 2021.

Based on HBK Investments's 13F filing for Q2 2021, filed 16 Aug 2021.